Compare · SYK vs ZBH
SYK vs ZBH
Side-by-side comparison of Stryker Corporation (SYK) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. SYK focuses on Medical/Dental Instruments, while ZBH focuses on Industrial Specialties.
- SYK is the larger of the two at $119.19B, about 6.2x ZBH ($19.20B).
- ZBH has been more active in the news (16 items in the past 4 weeks vs 13 for SYK).
- Both have 25 recent analyst ratings on file.
- Company
- Stryker Corporation
- Zimmer Biomet Holdings Inc.
- Price
- -
- -
- Market cap
- $119.19B
- $19.20B
- 1M return
- +2.84%
- -
- 1Y return
- -12.35%
- -
- Industry
- Medical/Dental Instruments
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 13
- 16
- Recent ratings
- 25
- 25
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest SYK
- Director Ronda E Stryker exercised 3,605 shares at a strike of $122.51, increasing direct ownership by 473% to 4,367 units (SEC Form 4)
- Director Stryker Ronda E sold $178,924,731 worth of shares (550,000 units at $325.32) (SEC Form 4)
- Stryker Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Stryker announces intention to nominate Jim Davis to board of directors
- What 3.4% GDP Growth and a 4.2% Jobless Rate Say About a Hard Day on Wall Street
- SEC Form S-3ASR filed by Stryker Corporation
- SEC Form IRANNOTICE filed by Stryker Corporation
- SEC Form 10-Q filed by Stryker Corporation
- Stryker downgraded by Canaccord Genuity with a new price target
- SEC Form 8-K filed by Stryker Corporation
Latest ZBH
- Zimmer Biomet upgraded by Wells Fargo with a new price target
- SEC Form CERT filed by Zimmer Biomet Holdings Inc.
- SEC Form 8-A12B filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 424B5 filed by Zimmer Biomet Holdings Inc.
- SEC Form 424B5 filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London
- Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery
- SEC Form FWP filed by Zimmer Biomet Holdings Inc.
- SEC Form FWP filed by Zimmer Biomet Holdings Inc.